Clinical Trial Results:
            Double-blind, three-way cross-over, placebo controlled study to assess the efficacy, safety and mechanisms of treatment with rupatadine 20 and 40mg in cold contact urticaria (CCU)
    
|     Summary | |
|     EudraCT number | 2011-004094-93 | 
|     Trial protocol | DE ES | 
|     Global completion date | 
                                    02 Jul 2013
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    11 Dec 2020
                             | 
|     First version publication date | 
                                    11 Dec 2020
                             | 
|     Other versions | |
|     Summary report(s) | results-CT_publication_2011-004094-93 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
